NCT04319263View on ClinicalTrials.gov

Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer

NACompletedINTERVENTIONAL

Enrollment

1,600

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions

Bladder Cancer

Interventions

DRUG

induction regimen of intravesical BCG

intravesical instillation of 6 weekly doses of BCG

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors

lead

Mansoura University

OTHER

NCT04319263 - Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter